Prenetics Global PRE
NASDAQ PRE
$24.19 +0.00 (+0.00%)
At close: Sep 18, 2026 · 4:00 PM EDT

Prenetics Global (PRE) Gains from Sales and Divestitures (2025 - 2026)

Prenetics Global's (PRE) quarterly Gains from Sales and Divestitures came in at -$253000.0 in Q1 2026, down 2200.0% quarter-over-quarter from -$11000.0 in Q4 2025.

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo
Analysis

Prenetics Global (PRE) Gains from Sales and Divestitures (2025 - 2026) Analysis & Trends

Prenetics Global (PRE) has reported Gains from Sales and Divestitures for 2 consecutive years, with -$253000.0 the latest figure, recorded in Q1 2026.

Peer Set

Peer Comparison

All peers
# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 GE HealthCare Technologies 28.97 Bn 27.09 Bn 2.18 Bn
2 Lantheus Holdings 6.56 Bn 5.97 Bn 241.86 Mn
3 Heartflow 4.40 Bn 4.03 Bn 53.19 Mn
4 Neogen 2.83 Bn 2.64 Bn 107.80 Mn
5 Butterfly Network 1.88 Bn 1.75 Bn 23.29 Mn
6 Ceribell 931.50 Mn 802.24 Mn 25.94 Mn
7 Varex Imaging 779.32 Mn 694.02 Mn 76.70 Mn
8 Anbio Biotechnology 755.43 Mn 743.53 Mn -
9 QuidelOrtho 725.35 Mn 601.95 Mn -
10 Prenetics Global 339.92 Mn 280.78 Mn 30.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -253,000.00
Dec 31, 2025 -11,000.00